Back to Search Start Over

Impact of the COVID-19 pandemic on clinical autonomic practice in Europe A survey of the European Academy of Neurology (EAN) and the European Federation of Autonomic Societies (EFAS).

Authors :
Fanciulli A
Leys F
Krbot Skorić M
Carneiro DR
Calandra-Buonaura G
Camaradou J
Chiaro G
Cortelli P
Falup-Pecurariu C
Granata R
Guaraldi P
Helbok R
Hilz MJ
Iodice V
Jordan J
Kaal ECA
Kamondi A
Pavy Le Traon A
Rocha I
Sellner J
Senard JM
Terkelsen A
Wenning GK
Moro E
Berger T
Thijs RD
Struhal W
Habek M
Source :
European journal of neurology [Eur J Neurol] 2023 Mar 15. Date of Electronic Publication: 2023 Mar 15.
Publication Year :
2023
Publisher :
Ahead of Print

Abstract

Objective: To investigate the impact of the coronavirus-disease-2019 (COVID-19) pandemic on European clinical autonomic practice.<br />Methods: Eighty-four neurology-driven or interdisciplinary autonomic centers in 22 European countries were invited to fill in a web-based survey between September and November 2021.<br />Results: Forty-six centers completed the survey (55%). During the first pandemic year, the number of performed tilt-table tests, autonomic outpatient and inpatient visits decreased respectively by 50%, 45% and 53%, and every-third center reported major adverse events due to postponed examinations or visits. The most frequent newly-diagnosed or worsened cardiovascular autonomic disorders after COVID-19 infection included postural orthostatic tachycardia syndrome (POTS), orthostatic hypotension, and recurrent vasovagal syncope, deemed likely related to the infection by ≥50% of the responders. Forty-seven percent of the responders also reported about people with new-onset of orthostatic intolerance, but negative tilt-table findings, and 16% about people with psychogenic pseudosyncope after COVID-19. Most patients were treated non-pharmacologically and symptomatic recovery at follow-up was observed in ≥45% of cases. By contrast, low frequencies of newly-diagnosed cardiovascular autonomic disorders following COVID-19 vaccination were reported, most frequently POTS and recurrent vasovagal syncope, and most of the responders judged a causal association unlikely. Non-pharmacological measures were the preferred treatment choice, with 50-100% recovery rates at follow-up.<br />Conclusions: Cardiovascular autonomic disorders may develop or worsen following a COVID-19 infection, while the association with COVID-19 vaccines remains controversial. Despite the severe pandemic impact on European clinical autonomic practice, a specialized diagnostic work-up was pivotal to identify non-autonomic disorders in people with post-COVID-19 orthostatic complaints.<br /> (This article is protected by copyright. All rights reserved.)

Details

Language :
English
ISSN :
1468-1331
Database :
MEDLINE
Journal :
European journal of neurology
Publication Type :
Academic Journal
Accession number :
36920252
Full Text :
https://doi.org/10.1111/ene.15787